Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Q: What does CUSIP 92840H400 represent in this 13F holders report?

CUSIP 92840H400 is the security identifier for VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2024?

41 institutional investors reported VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 92840H400

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 14,613,555
Total 13F value: $76,690,483
Share change: -296,340
Put/Call ratio: 21%
SEC-reported price per share: $5.28
Number of holders: 41
Value change: -$1,575,877
Number of buys: 19
Number of sells: 20
Shares outstanding: 42,874,646

Security key

92840H400

Report period

Q1 2024

Institutions

Top holders

VTGN full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Vistagen Therapeutics, Inc. SEC filings Vistagen Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92840H400

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Venrock Healthcare Capita...

Disclosed value leader

Venrock Healthcare Capita...

Comparable rows

0/15

Latest evidence

31 Dec 2023

3/4/5 13F Highest disclosed value: $35,434,220 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Venrock Healthcare Capital Partners II, L.P. has the largest disclosed position value at $35.43M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Venrock Healthcare Capital Partners II, L.P.'s linked filing trail.

Disclosed position value Top 5

Venrock Healthcare Capital Partne... $35.43M

Commodore Capital LP $8.1M

TCG Crossover Management, LLC $13.76M

BVF INC/IL $10.28M

GREAT POINT PARTNERS LLC $9.55M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Venrock Healthcare Capital Partners II, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$35,434,220 20,637,286 shares	—	12 Jul 2022
Commodore Capital LP	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— mixed-class rows	$8,095,500 1,575,000 shares	—	31 Dec 2023
TCG Crossover Management, LLC	13F Company 13F	— denominator unverified	$13,757,621 2,676,580 shares	—	31 Dec 2023
BVF INC/IL	13F Company 13F	— denominator unverified	$10,280,000 2,000,000 shares	—	31 Dec 2023
GREAT POINT PARTNERS LLC	13F Company 13F	— denominator unverified	$9,553,898 1,858,735 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$9,429,391 1,834,512 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

14,613,555

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend